Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine, Topiramate, CBT, and DBT in Bulimia Nervosa
NCT04154813Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Feb 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of topiramate and fluoxetine in bulimia nervosa (BN), sponsored by Shanghai Mental Health Center. Primary endpoint: Eating Disorder Examination-Self-Report Questionnaire at 12 months. Status: unknown.
02
Drugs
topiramatefluoxetine
03
Conditions
bulimia nervosa (BN)
Beyond the preview
Go deeper on NCT04154813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04154813.